Status:
COMPLETED
Feasibility of a Rehabilitation Programme Targeted Patients Treated With Non-myeloablative Stem Cell Transplantation
Lead Sponsor:
Aarhus University Hospital
Conditions:
Stem Cell Transplantation
Rehabilitation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Non-myeloablative allogeneic haematopoietic stem cell transplantation (NMA-HSCT) is associated with innumerable complications and side-effects and a high treatment-related mortality. Maintaining quali...
Detailed Description
Rehabilitation is becoming increasingly important in the face of growing diversity and intensity of cancer treatment and so is treatment with haematopoietic stem cell transplantation from a donor. Non...
Eligibility Criteria
Inclusion
- Patients were accepted for NMA-HSCT
- ≥ 18 years
- able to read and understand Danish and to follow the study protocol.
Exclusion
- psychological diagnosis
- contra-indications for progressive exercise training
- inability to walk or stand
- instable bone lesions
- severe neurological deficiencies
- severe cardiac or cardio vascular diseases, severe pulmonary global insufficiency.
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04798495
Start Date
September 1 2018
End Date
July 1 2021
Last Update
November 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dep. of Hem. Aarhus Universitetshospital
Aarhus, Denmark